SBIR and STTR Success Story for
Vecna Technologies

(Information Posted/Updated on 02/24/2011)

Vecna Technologies
6404 Ivy Lane
Greenbelt, MD  20770

Contact:    Michael Bearman
Phone:      (877) 864-7250
Web Site:

Project Title:  QC PathFinder: Signal-Based Analysis of Clinical Microbiology
Related Award(s):  5 R44 AI048332-03
Technology Developed:
Vecna Technologies developed software and algorithms to detect potential outbreaks of healthcare-acquired infections and track antimicrobial resistance trends amongst various pathogens.

Key Words:  healthcare acquired infec, antimicrobial stewardship, antimicrobial resistance, infection control, nosocomial, infection surveillance, infection prevention.
Uses of Technology/Products/Service:
Infection control teams within hospitals use QC PathFinder for daily reporting and surveillance, public health reporting, and intervention tracking. The software also serves as an integral part of a hospital's antimicrobial stewardship program, identifying opportunities to intervene for reasons of safety, clinical effectiveness, and potential cost savings. Many hospitals using QC PathFinder have noted decreases in both healthcare-acquired infection rates and in annual antibiotic cost.

Benefit to Company:
The SBIR program has had a significant impact on the ability of Vecna to develop and market this software product. Working with Massachusetts General Hospital and Boston Children’s Hospital as part of this grant, Vecna developed a robust technology platform on which all new releases have been built. Data obtained from research under this grant enabled Vecna to validate its HAI (healthcare-acquired infection) detection algorithms and its automated institutional antibiogram with clinical partners.

The newest release of the QC PathFinder product has extensive capabilities in both infection control and antimicrobial stewardship. The flexible reporting platform provides hospitals with a custom approach to data mining their laboratory, microbiology, pharmacy, and surgical data feeds. External reporting capabilities also support reporting Reportable Communicable Diseases to state and local, as well as HAI reports to the Centers for Disease Control and Prevention (CDC) National Health Safety Network.

The combination of these features, developed on top of an SBIR-funded platform, has allowed Vecna to provide significant benefits to its customers. Customers have cited 30% time savings in surveillance activities, declines in bloodstream infections in the ICU of up to 50%, and tangible savings in both length-of-stay and antibiotic spend regularly into the hundreds of thousands of dollars. The product represents multiple millions of dollars in revenue annually and helps infection preventionists protect over a million patients’ lives every year across all participating hospitals.

The SBIR program has allowed Vecna to utilize a robust technology platform to create the leading infection prevention and antimicrobial stewardship software solution on the market.

Please contact for more information on company benefit.

How Product Was Commercialized:
Following success with early adopters as part of the SBIR-funded R&D program, Vecna quickly expanded market share in both the commercial and public sector markets. The Department of Veterans Affairs in 2007 selected Vecna’s QC PathFinder in a competitive bid as the VA’s enterprise infection control surveillance solution. Vecna’s customers continue to achieve new successes with the QC PathFinder infection prevention and antimicrobial stewardship solution.